Not only is Valeant Pharmaceuticals (NYSE:VRX) reportedly prepping a bid for Salix Pharmaceuticals (NASDAQ:SLXP), but Shire (NASDAQ:SHPG) is now rumored to be preparing an offer. Shire has taken initial steps towards a bid and is evaluating how to secure financing, sources told Reuters. Yesterday, Valeant Pharmaceuticals (VRX) was reported to be arranging financing for a takeout of Salix at a likely price of more than $150 per share. Including net debt, Salix is valued at almost $11B. Previously: Valeant close to a bid for Salix (Feb. 12 2015) SLXP +1.2% premarket http://seekingalpha.com/news/2297376-shire-now-on-the-hunt-for-salix#